✦ LIBER ✦

The antitumour activity of the prodrug N-l-leucyl-doxorubicin and its parent compound doxorubicin in human tumour xenografts

✍ Scribed by K. Breistøl; H.R. Hendriks; D.P. Berger; S.P. Langdon; H.H. Fiebig; O. Fodstad

Book ID: 117665869
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 93 KB
Volume: 34
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(98)00152-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Study of the Safety and Antitum

Phase II Study of the Safety and Antitumor Activity of the Hypoxia-Activated Prodrug TH-302 in Combination With Doxorubicin in Patients With Advanced Soft Tissue Sarcoma

✍ Chawla, S. P.; Cranmer, L. D.; Van Tine, B. A.; Reed, D. R.; Okuno, S. H.; Butry 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 598 KB